首页> 外文期刊>Nature Communications >Warhead biosynthesis and the origin of structural diversity in hydroxamate metalloproteinase inhibitors
【24h】

Warhead biosynthesis and the origin of structural diversity in hydroxamate metalloproteinase inhibitors

机译:弹头生物合成和异羟肟酸金属蛋白酶抑制剂结构多样性的起源

获取原文
       

摘要

Metalloproteinase inhibitors often feature hydroxamate moieties to facilitate the chelation of metal ions in the catalytic center of target enzymes. Actinonin?and matlystatins are potent metalloproteinase inhibitors that comprise?rare N-hydroxy-2-pentyl-succinamic acid warheads. Here we report the identification and characterization?of their biosynthetic pathways. By gene cluster comparison and a combination of precursor feeding studies, heterologous pathway expression and gene deletion experiments we are able to show that the N-hydroxy-alkyl-succinamic acid warhead is generated by an unprecedented variation of the ethylmalonyl-CoA pathway. Moreover, we present evidence that the remarkable structural diversity of matlystatin congeners originates from the activity of a decarboxylase-dehydrogenase enzyme with high similarity to enzymes that form epoxyketones. We further exploit this mechanism to direct the biosynthesis of non-natural matlystatin derivatives. Our work paves the way for follow-up studies on these fascinating pathways and allows the identification of new protease inhibitors by genome mining.
机译:金属蛋白酶抑制剂通常具有异羟肟酸酯部分,以促进目标酶催化中心金属离子的螯合。肌动蛋白和马他汀类药物是有效的金属蛋白酶抑制剂,包含少量N-羟基-2-戊基琥珀酸弹头。在这里,我们报告其生物合成途径的鉴定和表征。通过基因簇比较和前体摄食研究,异源途径表达和基因缺失实验的组合,我们能够证明N-羟烷基琥珀酸氨基磺酸战斗部是由乙基丙二酰辅酶A途径的前所未有的变化产生的。此外,我们目前的证据表明,马来他汀同类物的显着结构多样性源自与形成环氧酮的酶具有高度相似性的脱羧酶-脱氢酶的活性。我们进一步利用这种机制来指导非天然matstatin衍生物的生物合成。我们的工作为这些引人入胜的途径的后续研究铺平了道路,并允许通过基因组挖掘鉴定新的蛋白酶抑制剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号